# A Phase IV Study to Evaluate the Immunogenicity and Safety in UK Laboratory Workers of Menitorix

> **NCT00503165** · PHASE4 · COMPLETED · sponsor: **Public Health England** · enrollment: 30 (estimated)

## Conditions studied

- Vaccination

## Interventions

- **BIOLOGICAL:** Menitorix (MenC and Hib conjugate)

## Key facts

- **NCT ID:** NCT00503165
- **Lead sponsor:** Public Health England
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** —
- **Final completion:** 2007-08
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2019-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00503165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00503165, "A Phase IV Study to Evaluate the Immunogenicity and Safety in UK Laboratory Workers of Menitorix". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00503165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*